ATACAND is indicated for the treatment of hypertension in adults and children 1 to <17 years of age. It may be used alone or in combination with other antihypertensive agents.1
Examine results of the CLAIM trials and the blood pressure lowering effect that ATACAND, a
once-daily angiotensin II type-1 receptor blocker (ARB), demonstrated vs losartan.15,16
This product information is intended for US health care professionals only.
Atacand and Atacand HCT are registered trademarks of the AstraZeneca group of companies. ©2016 AstraZeneca. All rights reserved. 2005404-3250804 Last Updated 6/16
Manufactured under the license from Takeda Pharmaceutical Company, Ltd. by: AstraZeneca AB, S-151, 85 Södertälje, Sweden